SEC Company Response from YIELD10 BIOSCIENCE, INC. (YTEN) (CIK 0001121702) — Mar 30, 2020
YIELD10 BIOSCIENCE, INC. (YTEN) (CIK 0001121702)
Date: March 30, 2020 · CIK: 0001121702 · Accession: 0001121702-20-000026
AI Filing Summary & Sentiment
Letter
VIA EDGAR Attention: Sergio Chinos, Esq. Yield10 Bioscience, Inc. Registration Statement on Form S-1 File No. 333 237420 Request for Acceleration
Re:
Dear Mr. Chinos:
Pursuant to Rule 461 of Regulation C promulgated under the Securities Act of 1933, as amended, Yield10 Bioscience, Inc. (the “Registrant”) hereby requests acceleration of the effective date of its Registration Statement on Form S-1 (File No. 333 237420), so that it may become effective at 10:00 a.m. (Washington, D.C. time) on April 2, 2020, or as soon thereafter as practicable.
Please call Megan Gates, of Mintz, Levin, Cohn, Ferris, Glovsky and Popeo, P.C., counsel to the Registrant, at (617) 348-4443 with any comments or questions regarding this matter.
Very truly yours,
Yield10 Bioscience, Inc.
Show Raw Text
CORRESP 1 filename1.htm Document Yield10 Bioscience, Inc. 19 Presidential Way Woburn, Massachusetts 01801 March 30, 2020 VIA EDGAR U.S. Securities and Exchange Commission Division of Corporation Finance 100 F Street, N.E. Washington, D.C. 20549 Attention: Sergio Chinos, Esq. Re: Yield10 Bioscience, Inc. Registration Statement on Form S-1 File No. 333 237420 Request for Acceleration Dear Mr. Chinos: Pursuant to Rule 461 of Regulation C promulgated under the Securities Act of 1933, as amended, Yield10 Bioscience, Inc. (the “Registrant”) hereby requests acceleration of the effective date of its Registration Statement on Form S-1 (File No. 333 237420), so that it may become effective at 10:00 a.m. (Washington, D.C. time) on April 2, 2020, or as soon thereafter as practicable. Please call Megan Gates, of Mintz, Levin, Cohn, Ferris, Glovsky and Popeo, P.C., counsel to the Registrant, at (617) 348-4443 with any comments or questions regarding this matter. Very truly yours, Yield10 Bioscience, Inc. By: /s/ Charles B. Haaser Name: Charles B. Haaser Title: Vice President, Finance, Chief Accounting Officer and Treasurer cc: Yield10 Bioscience, Inc. Oliver P. Peoples, Ph.D. Mintz, Levin, Cohn, Ferris, Glovsky and Popeo, P.C. Megan N. Gates, Esq.